ERBB2 and ependymoma: Taken together, our findings demonstrate that ErbB2 is a critical regulator of Nf2-deficient SC NPC survival and glial differentiation, and support further evaluation in preclinical and human clinical trials for NF2-associated and select sporadic ependymomas.